Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

For more than two decades, researchers at the University of Basel, Switzerland, have been investigating a severe form of ...

Semaglutide shows potential for weight loss in older adults without harming bone density, but longer studies are essential to ...